Percutaneous Radiofrequency Ablation with or without Chemolipiodolization for Hepatocellular Carcinoma: A Propensity-Score-Matched Analysis

Chemolipiodolization (CL) is less invasive than transarterial chemoembolization (TACE) for managing hepatocellular carcinoma (HCC) because it helps avoid embolization. However, the treatment outcomes of percutaneous radiofrequency ablation (PRFA) with or without CL for HCC remain unclear. Herein, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Takaki, Kota, Nakano, Masahito, Fukumori, Kazuta, Yano, Yoichi, Zaizen, Yuki, Niizeki, Takashi, Kuwaki, Kotaro, Fukahori, Masaru, Sakaue, Takahiko, Yoshimura, Sohei, Nakazaki, Mika, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953328/
https://www.ncbi.nlm.nih.gov/pubmed/35329809
http://dx.doi.org/10.3390/jcm11061483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953328/
https://www.ncbi.nlm.nih.gov/pubmed/35329809
http://dx.doi.org/10.3390/jcm11061483

Ejemplares similares